Department of Biostatistics

July 21, 2022

Epidemiology PhD program receives CEPH accreditation

The Vanderbilt Epidemiology PhD Program has received accreditation from the Council on Education for Public Health (CEPH).

By Leigh MacMillan
June 30, 2022

Davidson named to receive the Geoffrey David Chazen Faculty Award for Innovation in Medical Education

The Academy for Excellence in Education is pleased to announce Mario Davidson, PhD, is the recipient of the 2022 Geoffrey David Chazen Faculty Award for Innovation in Medical Education.

By VUMC News and Communications
June 16, 2022

Grant to help train biostatisticians in West Africa

Vanderbilt and Aminu Kano Teaching Hospital have partnered on a new program to train a cohort of highly skilled Nigerian biostatisticians to lead and supervise high-level biostatistics activities for HIV research studies in West Africa.

By Kristin Centers
June 8, 2022

Capacity-building grant trains biostatisticians in West Africa

The Vanderbilt Institute for Global Health, Vanderbilt Department of Biostatistics, and Aminu Kano Teaching Hospital (AKTH) have partnered on a new program to train a cohort of highly skilled Nigerian biostatisticians to lead and supervise high-level biostatistics activities for HIV research studies in West Africa. 

By Kristin Centers
June 2, 2022

Sex & race & door-to-ECG time

More than a third of patients presenting at the emergency department with a suspected heart attack have a “delayed” ECG measure of heart function, with Black patients, females and non-English speakers more likely to experience delays.

By Paul Govern
March 22, 2022

VUMC’s Pietenpol, Shyr named AACR Fellows

Vanderbilt’s Jennifer Pietenpol, PhD, and Yu Shyr, PhD, have been inducted as fellows of the American Association for Cancer Research Academy.

By Tom Wilemon
January 31, 2022

Impact of digital health interventions

Vanderbilt researchers test and recommend statistical approaches to study the association between engagement with digital health interventions and clinical outcomes.
By Leigh MacMillan
January 14, 2022

Vanderbilt biostatisticians launch Cancer-Immu data portal for predicting response to immune checkpoint blockade immunotherapy

A new data portal called Cancer-Immu established by a team of Vanderbilt University Medical Center biostatisticians can help cancer clinicians and researchers predict which patients will respond to immune checkpoint inhibitors.
By Tom Wilemon
November 11, 2021

VUMC team puts tool to reduce heart failure admissions to test

Vanderbilt researchers have developed a risk stratification tool to predict outcomes and avoid unnecessary hospital admissions after emergency department visits for acute heart failure.
By Bill Snyder
November 11, 2021

VUMC tests drugs for COVID outpatient treatment

By Paul Govern
September 9, 2021

Raman, Balucan receive health equity research grants

Vanderbilt researchers Rameela Raman, PhD, and Francis Balucan, MD, MBA, are the recipients of the first annual Vanderbilt Center for Health Services Research (CHSR) Health Equity Research Grants.
By Craig Boerner
July 27, 2021

Prediction models for breast cancer

Vanderbilt researchers developed new prognostic models for breast cancer outcomes and found that adding postdiagnostic weight change as a factor improves the prediction.
By Leigh MacMillan
April 15, 2021

Method proposed to correct misinterpretations of long-term survival rates for immunotherapies

Immune checkpoint inhibitors have transformed cancer care to the point where the popular Cox proportional-hazards model provides misleading estimates of the treatment effect, according to a new study published April 15 in JAMA Oncology.
By Tom Wilemon
1 2 3 4